NCT02825901

Efficacy Testing of Djulis-Buckwheat Drink on Cardiovascular Protection

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Taipei Medical University Hospital · Academic / Other
• Sex: All
• Age: 30 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the trial is to evaluate the effect of Djulis-Buckwheat drink on cardiovascular protection after ingesting for 8 weeks. In addition, the correlation between the supplement and the cardiovascular disease-related gene expression is evaluated. The results will be used for the application of functional products for cardiovascular protection. Ninety subjects (age 30\~65) with Prehypertension or Hypertension stage 1 will be included and randomly allocated into 3 groups: Placebo, Djulis-Buckwheat and Buckwheat. The subjects will take sample (100 ml/day) for 8 weeks. Blood pressure will be measured on week 0, 1, 2, 4, 6 and 8. The blood biochemical parameters and gene expression analysis will be examined on week 2, 4, 6, 8 and 10 (the follow up).

Conditions

• Prehypertension
• Hypertension Stage 1

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo	Ingest placebo drink 100ml/day for 8 weeks
DIETARY_SUPPLEMENT	Djulis-Buckwheat	Ingest Djulis-Buckwheat drink 100ml/day for 8 weeks
DIETARY_SUPPLEMENT	Buckwheat	Ingest Buckwheat drink 100ml/day for 8 weeks

Timeline

• Start date: 2019-03-01
• Primary completion: 2020-01-01
• Completion: 2020-12-01
• First posted: 2016-07-07
• Last updated: 2023-11-22